Alx Oncology Holdings (ALXO) Invested Capital (2019 - 2026)

Alx Oncology Holdings' Invested Capital history runs 8 years deep, the most recent figure standing at $156.6 million for Q1 2026.

• In Q1 2026, Invested Capital rose 73.89% year-over-year to $156.6 million; the TTM figure through Mar 2026 stood at $156.6 million (up 73.89% YoY), while the FY2025 annual figure was $31.2 million, down 72.65% from the prior year.
• Invested Capital came in at $156.6 million for Q1 2026 at Alx Oncology Holdings, up from $31.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $343.6 million in Q1 2022 to a low of $31.2 million in Q4 2025.
• A 5-year average of $177.0 million and a median of $164.2 million in 2024 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital plunged 72.65% in 2025 and surged 73.89% in 2026, its largest moves.
• Alx Oncology Holdings' Invested Capital stood at $265.1 million in 2022, then decreased by 28.44% to $189.7 million in 2023, then tumbled by 39.88% to $114.1 million in 2024, then slumped by 72.65% to $31.2 million in 2025, then soared by 401.84% to $156.6 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $156.6 million, $31.2 million, and $49.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison